Identifying the central nervous system sites of action of anaesthetics is important for understanding the link between their molecular actions and clinical effects. The aim of the present pilot study was to compare the anaesthetic effect of bilateral microinjections of propofol and thiopentone (both 200 µg/µl, in Intralipid and 0.9% saline respectively) into a recently discovered anaesthetic-sensitive region in the rat brainstem, the "mesopontine tegmental anaesthetic area" (MPTA). Microinjections (1 µl per side) were made into the MPTA of fifteen male Sprague-Dawley rats. The effect of each agent on spontaneous behaviour, postural control and nociceptive responsiveness was subjectively assessed according to established criteria. The main finding was that thiopentone induced an "anaesthesia-like" state, including complete atonia and loss of righting ability, in 20% of the subjects. Overall, thiopentone significantly reduced postural control and had a moderate antinociceptive effect compared to saline microinjections (P<0. 01 and 0.05, respectively, Wilcoxon test). In contrast, propofol did not induce "anaesthesia" in any animal tested, although a similar antinociceptive effect to that of thiopentone was observed (P<0.05, Wilcoxon test) . In summary, propofol and thiopentone have different effects when microinjected into the MPTA. While both agents reduced reflex withdrawal to a nociceptive stimulus, only thiopentone induced an "anaesthesia-like" state.
Despite recent advances in the understanding of the effects of general anaesthetics at the molecular and cellular levels, little is known about how these effects translate into the observable state of general anaesthesia, or whether there are specific anatomical pathways involved. Identifying the localized sites of action of anaesthetics is an important step towards linking their molecular actions to the clinically observed effects.
The most common view is that anaesthetics exert their effects in a widely distributive manner, in keeping with the ubiquitous distribution of anaestheticsensitive channels and receptors within the brain 1, 2 . There is growing evidence, however, that many of the clinically relevant effects of anaesthetics are the result of regionally specific effects. For example, loss of movement responses to noxious stimuli (the basis of the clinical measure of anaesthetic potency) is mediated predominantly by spinal cord effects 3, 4 .
Recent intracerebral microinjection studies have provided the first direct experimental evidence that the sedative and hypnotic actions of some GABAergic anaesthetics may be attributable to effects within discrete areas of the brainstem activating system. For example, injection of the GABA(A) agonist muscimol into the tuberomamillary nucleus (TMN) resulted in a loss-of-righting reflex (LORR) and injection of the GABA(A)-mediated anaesthetics propofol and pentobarbitone, induced "marked sedation". By contrast, injection of gabazine, a GABA(A) antagonist, into the TMN decreased the duration of the LORR produced by systemic administration of propofol and pentobarbitone 5 . Similar results have been obtained for a circumscribed region of the mesopontine tegmentum. Devor and Zalkind 6 systematically surveyed subcortical regions of the rat brain for a focal anatomical site of barbiturate anaesthetic action. They found that microinjection of pentobarbitone into the mesopontine region of rats was effective at producing an anaesthesia-like state in about three-quarters of the subjects, while injections outside of this circumscribed area were ineffective. They termed this anaesthetic-sensitive region the "mesopontine tegmental anaesthetic area" (MPTA).
In the present work we sought to determine whether the MPTA is also sensitive to the intravenous anaesthetic agent propofol. We were particularly interested in propofol because, although it is structurally dissimilar to the anaesthetic barbiturates, it is believed to share a common mechanism of action with them, i.e. enhancement of GABAergic inhibitory activity through binding at GABA(A) receptors 7 . Moreover, propofol is at least as potent as thiopentone 8 . Given its mechanism of action and relative potency, our hypothesis was that equivalent doses of propofol and the barbiturate thiopentone would have similar anaesthetic effects when microinjected into the mesopontine anaesthetic area.
METHODS

Animals
Fifteen male Sprague-Dawley rats, weighing 400-600 g at the time of surgery, served as subjects. The rats were maintained on a 12:12-hour light-dark cycle, were individually housed following surgery, and had ad libitum access to food and water. Ethics approval for this study was granted by the Ruakura Animal Ethics Committee.
Surgery
Animals were anaesthetized with ketamine/ xylazine (75/10 mg/kg, i.p.) and mounted in a stereotaxic instrument with the skull level. Five holes were drilled in the exposed skull, three for stainless steel skull screws and two for 25-gauge stainless steel microinjection guide cannulae. The guide cannulae were positioned in the mesopontine region of the brainstem with the tips aimed at the following stereotaxic coordinates, according to Paxinos and Watson 9 : 8.3 mm caudal to bregma, ±1.3 mm lateral to the midline, and 6.5 mm ventral to the cortical surface. The guide cannulae were cemented to the three stainless steel anchor screws with dental acrylic (GC Corporation, Tokyo, Japan). In addition, for the purposes of EEG recording, insulated wires were attached to the anchor screws of eight of the rats and terminated in a plastic three-pin socket, the base of which was embedded in the dental acrylic. Screw placements were bilateral over the parietal cortex (active electrodes) and in the midline over the cerebellum (reference electrode), as previously described 6 . Yohimbine (0.1 mg/kg, Sigma), an alpha2-adrenergic receptor antagonist, was administered intraperitoneally immediately following surgery. The animals were allowed to recover for at least seven days prior to testing.
Microinjection protocol
The microinjection procedures were carried out 6-8 hours after the beginning of the light cycle to eliminate circadian effects. For drug microinjection, the animals were removed from their cages and gently restrained by hand while the obturators were removed from the guide cannulae and 31-gauge microinjection cannulae inserted. The injection cannulae extended 1 mm below the tips of the guides. All anaesthetic agents were delivered via 25 µl microsyringes (SGE, Melbourne, Australia) in a total volume of 1 µl over 1 minute, using a computerdriven syringe pump (BASi, West Lafayette, Indiana, U.S.A.). The injection cannulae were left in place for 1 minute following drug delivery. The animals were unrestrained during the microinjections.
Bilateral microinjections of 10 µg/µl (1%) propofol in Intralipid (Diprivan) were initially trialled in four of the animals. Thereafter, both thiopentone (Rhone-Poulenc Rorer, U.K.) and propofol were administered as 200 µg/µl solutions (n=15 and n=11, respectively), giving a total dose of 200 µg per side. Thiopentone was delivered in sterile 0.9% saline. The 200 µg/µl propofol solution was obtained by mixing the commercially available 10 µg/µl (1%) Intralipid solution (Diprivan ® ) with the appropriate volume of di-isopropylphenol (Sigma-Aldrich, Sydney, Australia). The solution was vortexed immediately prior to microinjection delivery. Sterile 0.9% saline was used as the control. The four animals that received 10 µg/µl of propofol were excluded from the propofol analysis.
Each animal received bilateral microinjections of the two study drugs and of saline. The order of injection was counterbalanced across subjects. Successive microinjections in individual animals were separated by two days to allow the prior agent to be fully cleared.
Behavioural rating of anaesthetic effect
Five minutes after drug delivery, the following behavioural assessment was performed, as described by Devor and Zalkind 6 . Briefly, the level of ataxia was observed in the freely moving animal and the righting reflex assessed by placing the animal on its side and noting the vigour of the righting response. Nociceptive responsiveness was tested by briefly applying a spring-loaded clasp to one hindfoot and to the base of the tail. The force applied was approximately 500 g (80 g/mm 2 ), which is moderately painful when applied to human skin. Each of the four parameters was scored on a scale of 0 (indicating a fully alert animal) to 4 (indicating the non-responsiveness of an animal under deep anaesthesia). Thus, a higher score reflected a greater anaesthetic/antinociceptive effect.
The "ataxia" and "righting reflex" scores were summed, giving a total "posture" component (out of 8) . Similarly, the foot and tail pinch scores were summed, giving a total "nociceptive" component (out of 8). These scores were used for further statistical analysis, as described below. The "total anaesthesia score" (out of 16) was the sum of the posture and nociceptive components, with a total anaesthesia score of 11 or greater designated as "moderate to deep reversible coma/anaesthesia" 6 .
EEG recording
Two animals were excluded from the EEG analysis because of damage to the skull-mounted electrical connectors, giving six animals from which a single channel bipolar EEG was obtained. The EEG was recorded before and after microinjection of each of the agents and again with induction of anaesthesia with systemic (intrahepatic) delivery of pentobarbitone (for transcardial perfusion -see below). The unfiltered EEG was recorded using a Bispectral Index anaesthetic monitor (Aspect Medical Systems Inc., Natick, U.S.A.) and downloaded onto a laptop computer for later offline power spectral analysis and 50 Hz filtering (MatLab ®, Mathworks, Natick, U.S.A.).
Histological assessment and statistical analysis
Following completion of the microinjections, the animals were anaesthetized with intrahepatic pentobarbitone (100 mg/kg) and perfused transcardially with 0.9% saline followed by 10% buffered formalin. The brains were then removed and stored in 10% formalin for a further 48 hours, followed by 48 hours in 30% sucrose-formalin. Coronal brain sections (40 µm) were cut on a cryostat, mounted on slides and stained with cresyl violet. The drug injection sites were located by light microscopy. Correct positioning within the MPTA 6 was confirmed in all animals with reference to Devor and Zalkind 6 and Paxinos and Watson 9 . We did not exclude animals on the basis of slight asymmetry in guide cannula placement.
The posture and nociception scores were compared between agents using the non-parametric Wilcoxon test for paired data. A P value of less than 0.05 was considered statistically significant. All data are presented as mean±SEM.
RESULTS
Microinjector placements
The placements of the guide cannulae are illustrated in Figure 1 . The cannulae were positioned between 7.04 to 8.0 mm caudal to bregma, 0.5 to 1.5 mm lateral to midline and 6.2 to 7.5 mm ventral to the surface of the cortex. These boundaries correspond closely to the MPTA defined by Devor and Zalkind 6 .
Anaesthesia scores
Paired comparisons using Wilcoxon's test showed that total anaesthesia scores for both propofol and thiopentone were significantly higher than those produced by saline (P<0.05 and P<0.003, respectively). For propofol, this predominantly reflected an antinociceptive effect (P<0.05), while thiopentone had a significant effect on both nociception (P<0.05) and postural control (P<0.01) ( Figure 2 ). Comparing the two anaesthetic agents, thiopentone had a greater effect on postural control than propofol (P<0.05), while no statistically significant difference in antinociceptive effect was observed between agents.
Thiopentone microinjections produced the highest total anaesthesia scores of the three agents tested (Figure 3 ). Three of the 15 animals microinjected with thiopentone had a total anaesthesia score of 11 or more (Figure 3a ), corresponding to "moderate to deep anaesthesia" as defined by Devor and Zalkind 6 . These animals exhibited complete loss of muscle tone and righting reflex, accompanied by variable degrees of antinociception. These effects began during the microinjections and lasted for 15 minutes to two hours. As the muscle atonia wore off these animals also exhibited occasional "startle" responses to light touch, spontaneous escape reactions and circling. Similar hyperexcitability and escape behaviours were observed in three other animals otherwise unresponsive to thiopentone microinjection. In contrast to thiopentone, the highest total anaesthesia score induced by propofol microinjection was 6 out of 16, in one animal (Figure 3b ). Hyperexcitability was not observed in any animal following propofol microinjection.
EEG analysis
EEG recordings were obtained from six animals. Microinjection of thiopentone, propofol or saline did not have a significant effect on the cortical EEG. In contrast, the EEG following induction of anaesthesia with systemic pentobarbital displayed a large increase in amplitude, predominantly in the theta (4-9 Hz) and beta (15-30 Hz) ranges (both P<0.05, Wilcoxon Test, n=5). These findings are illustrated in Figure 4 , which shows the EEG recorded from two animals, one during wakefulness and following thiopentone microinjection-induced "anaesthesia" (total anaesthesia score=11) (Figure 4a ), compared with a second animal during wakefulness and following induction of anaesthesia with systemic pentobarbitone (Figure 4b ).
DISCUSSION
The main finding of the present study was that thiopentone, but not propofol, induced an "anaesthesia-like" state in some animals when injected into the MPTA. In all, 20% of thiopentone microinjections resulted in moderate to deep anaesthesia, including complete atonia and loss of righting ability. A further 20% of animals had posture scores 5 or above, indicating significant loss of muscle tone and/or ataxia. Thiopentone also significantly reduced nociceptive responsiveness. By contrast, propofol had almost no effect on either muscle tonus and none on righting ability, but was approximately equivalent to thiopentone in terms of the degree to which it reduced nociceptive responsiveness.
Most anaesthetic agents are thought to act principally through the activation of GABA(A) receptormediated chloride currents 10 . Recent evidence, however, suggests that voltage sensitive Ca 2+ channels may also play a role in anaesthesia by depressing glutamatergic transmission 11 . Whatever their specific mechanism of action, the present finding that propofol and thiopentone do not have an equivalent hypnotic effect when injected in the same circumscribed area of the mesopontine tegmentum suggests that they may act on different GABA(A) receptor isoforms, and at different anatomical sites. This suggestion is consistent with previous findings that implicate different anatomical loci as important for the mediation of the hypnotic effects of pentobarbitone 6 and propofol l5,12 .
It was noteworthy that thiopentone induced an anaesthesia-like state in only 20% of the present animals, compared with 76% in Devor and Zalkind 6 . This was presumably due to subtle differences in microinjector placement between studies, as the distribution of injection sites was not appreciably different between studies. Inter-animal anatomical variation may have also contributed to the differences between studies. That apparently on-target micro-injections were ineffective is unlikely to be due to failure of drug delivery, as the patency of our microinjector cannulae were carefully checked prior to and after each microinjection. While injecting 1 µl from a 25 µl syringe may have introduced some variability in the volume delivered, this was limited by using high quality glass microsyringes and a computerdriven syringe pump. Also, the dead-space associated with the tubing and microinjection cannulae was accurately calculated and a volume in excess of this run for each test substance. solutions were made at each recording session. Importantly, microinjection of thiopentone at subcortical sites outside the MPTA are ineffective at inducing any anaesthetic effects 6 , confirming that the MPTA is an area of special significance for thiopentone anaesthesia.
While earlier studies concluded that propofol and barbiturates are non-analgesic, and in the case of the latter, possibly hyperalgesic, subsequent work has provided evidence of antinociceptive actions for both compounds 13 . This latter finding is consistent with the present work; propofol and thiopentone both caused a reduction in reflex withdrawal to paw and tail pinch. While nociception per se cannot be objectively assessed in animal models, these findings strongly imply an antinociceptive effect. Importantly, in the present work this effect was obtained with microinjections into the MPTA, suggesting that the antinociceptive effect of propofol and thiopentone is, at least in part, organized supraspinally.
Hyperexcitability and escape reactions were observed in a number of animals following thiopentone microinjection, with and without accompanying periods of atonia and ataxia. Interestingly, Devor and Zalkind 6 made no mention of hyperexcitability behaviours in the animals they studied. Spontaneous excitatory movements and intermittent jerking are sometimes observed clinically during induction of anaesthesia with propofol and thiopentone 14 . The CNS region and mechanism responsible for this excitatory effect is not known. Based on the above behavioural observations, we speculate that the paradoxical excitatory effects observed with some general anaesthetics may relate to GABAergic "disinhibition" of mesopontine locomotor pathways. Such "double negative" excitatory GABAergic effects are relatively common within the brainstem 15, 16 . An alternative possibility is that hyperexcitability and escape reactions following thiopentone administration are genuine behavioural reactions to aversive effects of the drug. Consistent with this explanation is the finding that rats exhibiting similar escape behaviour during electrical stimulation of the pedunculopontine tegmentum readily learn to terminate the stimulus by pressing a bar 17 .
An unknown variable in the present study is the extent to which each agent diffused from the microinjection site. A conservative estimate based on 1 µl dye microinjections is that the agents would have diffused to a volume of 1 mm 3 surrounding the injection site 18 . The high lipophilicity of both agents probably would have seen them spread (via transcellular diffusion) somewhat further than this 19, 20 . Also, the pattern of spread of thiopentone may have been different to that of propofol due to the fact thiopentone is highly water soluble and was administered in an aqueous solution whereas propofol is poorly water soluble and was given as a soy based emulsion 19, 20 . This study does not address the possibility that the different physical characteristics of the agents tested may have directly contributed to some of the variability in the observed results. For example, propofol is somewhat more lipid soluble than thiopental, has a lower pH (especially at the high concentrations used in the present study) and was delivered in viscous Intralipid.
Based on the diffusion characteristics described above, it is conceivable that spread from the microinjection site may have affected surrounding nuclei, including the pedunculopontine nucleus (PPN). During REM sleep in rats and cats [21] [22] [23] activity at the PPN is associated with marked muscle atonia, a feature of this stage of sleep. Microinjections of the GABA agonist muscimol into the PPN of cats 22 increased the ratio of REM sleep to non-REM sleep over the six hours studied 22 . It is possible that the observed "anaesthetic" effects following microinjection of thiopentone reflected a "REM sleep-like" state or a drug-induced "cataplexy". These suggestions are supported by the high frequency/low amplitude EEG obtained from a rat during thiopentoneinduced atonia in our study (see Figure 4 ).
There are two important considerations relating to the dose and concentration of agents used in the present study. First, a dose of 400 µg (0.67-1.0 mg/kg) administered intravenously would be insufficient to induce general anaesthesia in the rat 24 . Thus, while we did not measure the blood concentration of thiopentone following microinjection, there is little doubt that the effects observed were due to local brainstem influences. Also, the rapid onset of anaesthetic effects during microinjection suggests a localized effect. Secondly, assuming a 5 x dilution factor 18 and 78% CSF protein binding 6 , a 200 µg dose microinjected in 1 µl would give a final free drug concentration of 11.2 µg/µl (11.2 mg/ml). This is more than 200 x the induction cerebral tissue concentration of pentobarbital of 50 µg/ml in rats 25 . Based on these calculations, even the lowest effective microinjected dose in the Devor and Zalkind paper of 10 µg equates to ten times the brain concentration for induction of general anaesthesia with a barbiturate. A concern is that the observed effects at these concentrations of thiopentone are due to neuronal damage or non-GABA receptor effects.
However, thiopentone microinjections are unlikely to cause neuronal damage secondary to tonicity or alkalinity of the solution. Firstly, a 60 µg/µl dose of thiopentone is equally effective at inducing anaesthetic effects as the 200 µg/µl solution utilized in our study 6 and this lower dose is not appreciably hypertonic (osmolarity of sodium content approximately 0.34 osmol/l). Secondly, neither 20% propylene glycol in 10% ethanol (a strongly hyperosmolar and alkaline solution) nor lignocaine (which blocks neuronal activity completely) have any anaesthetic effect when microinjected into the MPTA 6 . Lastly, one would expect neuronal damage to result in permanent effects, however we observed no lasting behavioural changes in any of the subjects following thiopentone microinjection.
In conclusion, the results of this pilot study confirm that "anaesthetic-like" effects can be induced in the rat following microinjection of barbiturate anaesthetics into a mesopontine region of the brainstem, and that this area also appears to contribute to antinociceptive effects of propofol and thiopentone. These results support the presumption that thiopentone and propofol act on discrete neuronal pathways to cause general anaesthesia.
